Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Trauma Acute Care Surg. 2016 Aug;81(2):358–365. doi: 10.1097/TA.0000000000001056

Figure 5. Pulmonary ADAM-17 is reduced by intraluminal tranexamic acid following hemorrhagic shock.

Figure 5

C57BL/6J mice underwent 90 minutes of hemorrhagic shock followed by the intraluminal injection of tranexamic acid into the small intestine. Three hours later, lungs were analyzed for A. Pulmonary ADAM-17 protein and B. Pulmonary ADAM-17 activity. Results are expressed as mean ± SE; n=8/group. Abbreviations: HS= hemorrhagic shock; TXA= tranexamic acid; ADAM-17= A disintegrin and metalloproteinase;